Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E M Griffiths

Showing results (221-230 of 337) with videos related to

Pageof 34
Sort By:
The Journal of Allergy and Clinical Immunology|August 3, 2023
Integrated proteomics and genomics analysis of paradoxical eczema in psoriasis patients treated with biologicsAli Al-Janabi, Paul Martin, Adnan R Khan, et al.
Lancet (London, England)|August 28, 2015
Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritisMeghna Jani, Hector Chinoy, Richard B Warren, et al.
The British Journal of Dermatology|July 13, 2022
Incidence and prevalence of psoriasis in multiethnic Johor Bahru, Malaysia: a population-based cohort study using electronic health data routinely captured in the Teleprimary Care (TPC®) clinical information system from 2010 to 2020: Classification: EpidemiologySiew Eng Choon, Alison K Wright, Christopher E M Griffiths, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 29, 2025
Drug survival of IL-23 and IL-17 inhibitors versus other biologics for psoriasis: A British Association of Dermatologists Biologics and Immunomodulators Register cohort studyLeila Motedayen Aval, Zenas Z N Yiu, Oras A Alabas, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2023
Risk of serious infection and infection mortality in patients with psoriasis: A nationwide cohort study using the Taiwan National Health Insurance claims databaseTeng-Chou Chen, Ting-Chun Wang, Zenas Z N Yiu, et al.
The Journal of Investigative Dermatology|November 9, 2007
The effects of acute social stress on epidermal Langerhans' cell frequency and expression of cutaneous neuropeptidesC Elise Kleyn, Laura Schneider, Rosita Saraceno, et al.
Journal of the American Academy of Dermatology|May 17, 2016
Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasisPeter C M van de Kerkhof, Christopher E M Griffiths, Kristian Reich, et al.
Aging Cell|April 8, 2021
Peptide location fingerprinting reveals modification-associated biomarker candidates of ageing in human tissue proteomesMatiss Ozols, Alexander Eckersley, Kieran T Mellody, et al.
Trials|February 12, 2020
A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trialSuzie Cro, Prakash Patel, Jonathan Barker, et al.
International Journal of Dermatology|May 19, 2025
Epidemiology of Psoriasis in Poland: Prevalence, Incidence, and Mortality RatesJoanna Bartosińska, Jacek C Szepietowski, Dorota Raczkiewicz, et al.
Pageof 34

Showing results (221-230 of 337) with videos related to

Sort By:
Pageof 34
The Journal of Allergy and Clinical Immunology|August 3, 2023
Integrated proteomics and genomics analysis of paradoxical eczema in psoriasis patients treated with biologicsAli Al-Janabi, Paul Martin, Adnan R Khan, et al.
Lancet (London, England)|August 28, 2015
Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritisMeghna Jani, Hector Chinoy, Richard B Warren, et al.
The British Journal of Dermatology|July 13, 2022
Incidence and prevalence of psoriasis in multiethnic Johor Bahru, Malaysia: a population-based cohort study using electronic health data routinely captured in the Teleprimary Care (TPC®) clinical information system from 2010 to 2020: Classification: EpidemiologySiew Eng Choon, Alison K Wright, Christopher E M Griffiths, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 29, 2025
Drug survival of IL-23 and IL-17 inhibitors versus other biologics for psoriasis: A British Association of Dermatologists Biologics and Immunomodulators Register cohort studyLeila Motedayen Aval, Zenas Z N Yiu, Oras A Alabas, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2023
Risk of serious infection and infection mortality in patients with psoriasis: A nationwide cohort study using the Taiwan National Health Insurance claims databaseTeng-Chou Chen, Ting-Chun Wang, Zenas Z N Yiu, et al.
The Journal of Investigative Dermatology|November 9, 2007
The effects of acute social stress on epidermal Langerhans' cell frequency and expression of cutaneous neuropeptidesC Elise Kleyn, Laura Schneider, Rosita Saraceno, et al.
Journal of the American Academy of Dermatology|May 17, 2016
Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasisPeter C M van de Kerkhof, Christopher E M Griffiths, Kristian Reich, et al.
Aging Cell|April 8, 2021
Peptide location fingerprinting reveals modification-associated biomarker candidates of ageing in human tissue proteomesMatiss Ozols, Alexander Eckersley, Kieran T Mellody, et al.
Trials|February 12, 2020
A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trialSuzie Cro, Prakash Patel, Jonathan Barker, et al.
International Journal of Dermatology|May 19, 2025
Epidemiology of Psoriasis in Poland: Prevalence, Incidence, and Mortality RatesJoanna Bartosińska, Jacek C Szepietowski, Dorota Raczkiewicz, et al.
Pageof 34